© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
May 08, 2009
Prolonged dual antiplatelet therapy With aspirin and clopidogrel is recommended for all patients undergoing percutaneous coronary intervention.
September 01, 2008
SORT OUT II trial results support our current understanding of drug-eluting stent use: (1) there is no difference in efficacy or safety among different drug-eluting stents; (2) stent thrombosis rates are highest in the first month after stent implantation; and (3) late stent thrombosis rates are low and not influenced by discontinuation of clopidogrel therapy at 12 months.
Meta-Analysis Indicates SGLT2 Inhibitors Optimal for Heart Failure Treatment
New FMT Trial Halted Due to Effectiveness
Postponing Morning Rounds for Nurses May Lead to Sleep Improvement for Patients